Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy

Author： Sinn H.P.   Anton H.W.   Magener A.   von Fournier D.   Bastert G.   Otto H.F.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.5, 1998-04, pp. : 646-653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast-conserving therapy after previous irradiation for lymphoma

By Nguyen Sonia  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 845-849

Springer Publishing Company

Access to resources Recommend Favorite

Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 223-224

Informa Healthcare

Access to resources Recommend Favorite

Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast‐conserving therapy

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 56-63

John Wiley & Sons Inc

Access to resources Recommend Favorite

Family history of breast cancer and local recurrence after breast-conserving therapy

By Brekelmans C.T.M.   Voogd A.C.   Botke G.   van Geel B.N.   Rodrigus P.   Rutgers E.J.T.   Klijn J.G.M.   Coebergh J.W.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 620-626

Elsevier

Access to resources Recommend Favorite

Arm Morbidity after Breast-conserving Therapy for Breast Cancer

By Tengrup Ingrid   Tennvall-Nittby Lena   Christiansson Inger   Laurin Marianne  

Acta Oncologica, Vol. 39, Iss. 3, 2000-10 ,pp. : 393-397

Informa Healthcare

Access to resources Recommend Favorite